BeOne Medicines AG
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | $-93.1M | $-119.2M | $-57.1M | $-18.3M |
| Depreciation & Amortization | $4.8M | $1.9M | $1.5M | — |
| Depreciation | $4.3M | $1.9M | $1.5M | $1.6M |
| Amortization | $250.0K | $0 | $0 | — |
| Stock-Based Compensation | $42.9M | $10.6M | $10.2M | $6.6M |
| Net Cash from Operating Activities | $12.8M | $-89.5M | $-39.8M | $-8.7M |
| Investing Activities | ||||
| Capital Expenditures | $46.4M | $23.5M | $5.3M | $654.0K |
| Business Acquisitions | — | — | — | — |
| Net Cash from Investing Activities | $-356.3M | $-221.8M | $-58.9M | — |
| Financing Activities | ||||
| Dividends Paid | — | — | — | — |
| Stock Repurchases | — | — | — | — |
| Net Cash from Financing Activities | $490.4M | $380.9M | $103.2M | — |
| Net Change in Cash | $152.1M | $69.6M | $4.0M | $10.0M |
| Free Cash Flow | $-33.6M | $-113.0M | $-45.2M | $-9.3M |